Advertisement
Screener

Fortress Biotech, Inc. (FBIO) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Fortress Biotech, Inc. Capital Expenditures

Fortress Biotech, Inc. (FBIO) reported Capital Expenditures of $79.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13

  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $28.00K, a 69.23% decline year-over-year.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $1.00K, a 99.90% decline year-over-year.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $63.00K, a 97.68% decline from fiscal 2022.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $2.71M, a 40.54% decline from fiscal 2021.
  • Fortress Biotech, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $4.57M, a 137.07% increase from fiscal 2020.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 3 month as first filedPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 9 month as first filedPayments to Acquire Property, Plant, and Equipment 12 monthPayments to Acquire Property, Plant, and Equipment 12 month as first filedPayments to Acquire Property, Plant, and Equipment 84 monthPayments to Acquire Property, Plant, and Equipment 87 monthPayments to Acquire Property, Plant, and Equipment 90 monthPayments to Acquire Property, Plant, and Equipment 93 month
2026-06-30$79.00K
10-Q · filed 2026-08-13
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$0.00
derived: sum of 2 quarters · filed 2025-03-31
$0.00
10-K · filed 2025-03-31
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$0.00
10-Q · filed 2024-11-14
2024-06-30$0.00
10-Q · filed 2024-08-13
2023-12-31$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$29.00K
derived: sum of 2 quarters · filed 2025-03-31
$63.00K
derived: sum of 3 quarters · filed 2025-03-31
$63.00K
10-K · filed 2025-03-31
2023-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$35.00K
derived: sum of 2 quarters · filed 2024-11-14
$35.00K
10-Q · filed 2024-11-14
$126.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$34.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$34.00K
10-Q · filed 2024-08-13
$125.00K
derived: sum of 3 quarters · filed 2024-08-13
$1.10M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$0.00
10-Q · filed 2023-05-15
$91.00K
derived: sum of 2 quarters · filed 2024-03-28
$1.07M
derived: sum of 3 quarters · filed 2024-03-28
$1.38M
derived: sum of 4 quarters · filed 2024-03-28
2022-12-31$91.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$1.07M
derived: sum of 2 quarters · filed 2024-03-28
$1.38M
derived: sum of 3 quarters · filed 2024-03-28
$2.71M
10-K · filed 2024-03-28
2022-09-30$980.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$1.29M
derived: sum of 2 quarters · filed 2023-11-14
$2.62M
10-Q · filed 2023-11-14
$4.58M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$307.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$1.64M
10-Q · filed 2023-08-14
$3.60M
derived: sum of 3 quarters · filed 2023-08-14
$4.06M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$1.34M
10-Q · filed 2023-05-15
$3.29M
derived: sum of 2 quarters · filed 2023-05-15
$3.75M
derived: sum of 3 quarters · filed 2023-05-15
$5.45M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$2.42M
derived: sum of 2 quarters · filed 2023-03-31
$4.11M
derived: sum of 3 quarters · filed 2023-03-31
$4.57M
10-K · filed 2023-03-31
2021-09-30$461.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$2.15M
derived: sum of 2 quarters · filed 2022-11-14
$2.61M
10-Q · filed 2022-11-14
$3.31M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$1.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$2.15M
10-Q · filed 2022-08-11
$2.85M
derived: sum of 3 quarters · filed 2022-08-11
$2.33M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$458.00K
10-Q · filed 2022-05-12
$1.16M
derived: sum of 2 quarters · filed 2022-05-12
$635.00K
derived: sum of 3 quarters · filed 2022-05-12
$1.86M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$698.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$177.00K
derived: sum of 2 quarters · filed 2022-03-28
$1.40M
derived: sum of 3 quarters · filed 2022-03-28
$1.93M
10-K · filed 2022-03-28
2020-09-30-$521.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$702.00K
derived: sum of 2 quarters · filed 2021-11-15
$1.23M
10-Q · filed 2021-11-15
$2.12M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$1.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$1.75M
10-Q · filed 2021-08-16
$1.09M
10-Q · filed 2020-08-10
$2.64M
derived: sum of 3 quarters · filed 2021-08-16
$3.14M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$526.00K
10-Q · filed 2021-05-17
$1.42M
derived: sum of 2 quarters · filed 2021-05-17
$1.92M
derived: sum of 3 quarters · filed 2021-05-17
$2.57M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$890.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-09
$1.39M
derived: sum of 2 quarters · filed 2021-04-09
$2.04M
derived: sum of 3 quarters · filed 2021-04-09
$2.35M
10-K/A · filed 2021-04-09
2019-09-30$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$1.16M
derived: sum of 2 quarters · filed 2020-11-09
$1.46M
10-Q · filed 2020-11-09
$1.79M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$655.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$955.00K
10-Q · filed 2020-08-10
$1.29M
derived: sum of 3 quarters · filed 2020-08-10
$3.42M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$300.00K
10-Q · filed 2020-05-11
$639.00K
derived: sum of 2 quarters · filed 2020-05-11
$2.77M
derived: sum of 3 quarters · filed 2020-05-11
$6.62M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$339.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$2.47M
derived: sum of 2 quarters · filed 2020-03-16
$6.32M
derived: sum of 3 quarters · filed 2020-03-16
$7.08M
10-K · filed 2020-03-16
2018-09-30$2.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$5.98M
derived: sum of 2 quarters · filed 2019-11-12
$6.74M
10-Q · filed 2019-11-12
$6.83M
10-Q · filed 2018-11-09
$6.39M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$3.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$4.61M
10-Q · filed 2019-08-09
$4.66M
10-Q · filed 2018-08-09
$4.26M
derived: sum of 3 quarters · filed 2019-08-09
$4.81M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$765.00K
10-Q · filed 2019-05-10
$801.00K
10-Q · filed 2018-05-10
$414.00K
derived: sum of 2 quarters · filed 2019-05-10
$959.00K
derived: sum of 3 quarters · filed 2019-05-10
$1.15M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$351.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$194.00K
derived: sum of 2 quarters · filed 2019-03-18
$387.00K
derived: sum of 3 quarters · filed 2019-03-18
$648.00K
10-K · filed 2019-03-18
$2.08M
10-K · filed 2018-03-16
2017-09-30$545.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$738.00K
derived: sum of 2 quarters · filed 2018-11-09
$999.00K
10-Q · filed 2018-11-09
$1.61M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30$193.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$454.00K
10-Q · filed 2018-08-09
$1.07M
derived: sum of 3 quarters · filed 2018-08-09
$2.52M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$261.00K
10-Q · filed 2018-05-10
$875.00K
derived: sum of 2 quarters · filed 2018-05-10
$2.33M
derived: sum of 3 quarters · filed 2018-05-10
$4.34M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$614.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$2.07M
derived: sum of 2 quarters · filed 2018-03-16
$4.08M
derived: sum of 3 quarters · filed 2018-03-16
$6.37M
10-K · filed 2018-03-16
2016-09-30$1.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$3.46M
derived: sum of 2 quarters · filed 2017-11-09
$5.76M
10-Q · filed 2017-11-09
$5.95M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$2.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$4.30M
10-Q · filed 2017-08-09
$4.49M
derived: sum of 3 quarters · filed 2018-03-16
$4.53M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$2.29M
10-Q · filed 2017-05-10
$2.48M
derived: sum of 2 quarters · filed 2018-03-16
$2.53M
derived: sum of 3 quarters · filed 2018-03-16
$2.58M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$189.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$234.00K
derived: sum of 2 quarters · filed 2018-03-16
$283.00K
derived: sum of 3 quarters · filed 2018-03-16
$283.00K
10-K · filed 2018-03-16
2015-09-30$45.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$94.00K
derived: sum of 2 quarters · filed 2016-11-09
$94.00K
10-Q · filed 2016-11-09
$94.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$49.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$49.00K
10-Q · filed 2016-08-09
$49.00K
derived: sum of 3 quarters · filed 2017-03-16
$49.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$0.00
10-Q · filed 2016-05-10
$0.00
derived: sum of 2 quarters · filed 2017-03-16
$0.00
derived: sum of 3 quarters · filed 2017-03-16
$0.00
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$0.00
derived: sum of 2 quarters · filed 2017-03-16
$0.00
derived: sum of 3 quarters · filed 2017-03-16
$0.00
10-K · filed 2017-03-16
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$0.00
derived: sum of 2 quarters · filed 2015-11-09
$0.00
10-Q · filed 2015-11-09
-$147.00K
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$0.00
10-Q · filed 2015-08-10
-$147.00K
derived: sum of 3 quarters · filed 2016-03-15
-$226.00K
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$0.00
10-Q · filed 2014-05-12
-$147.00K
derived: sum of 2 quarters · filed 2016-03-15
-$226.00K
derived: sum of 3 quarters · filed 2016-03-15
$38.00K
derived: sum of 4 quarters · filed 2016-03-15
$135.00K
10-Q · filed 2014-05-12
2013-12-31-$147.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$226.00K
derived: sum of 2 quarters · filed 2016-03-15
$38.00K
derived: sum of 3 quarters · filed 2016-03-15
$40.00K
10-K · filed 2016-03-15
$135.00K
10-K · filed 2014-03-14
2013-09-30-$79.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$185.00K
derived: sum of 2 quarters · filed 2014-11-06
$187.00K
10-Q · filed 2014-11-06
$507.00K
10-Q · filed 2013-11-01
2013-06-30$264.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$266.00K
10-Q · filed 2014-08-11
$586.00K
10-Q · filed 2013-08-05
2013-03-31$2.00K
10-Q · filed 2014-05-12
2012-12-31$54.00K
10-K · filed 2015-03-16
2011-12-31$0.00
10-K · filed 2014-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
PepGen Inc. (PEPG)United States$0.186B-1.73
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Nkarta, Inc. (NKTX)United States$0.205B-1.73
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39